Literature DB >> 28465516

Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia.

A M Eiring, B D G Page, I L Kraft, C C Mason, N A Vellore, D Resetca, M S Zabriskie, T Y Zhang, J S Khorashad, A J Engar, K R Reynolds, D J Anderson, A Senina, A D Pomicter, C C Arpin, S Ahmad, W L Heaton, S K Tantravahi, A Todic, R Colaguori, R Moriggl, D J Wilson, R Baron, T O'Hare, P T Gunning, M W Deininger.   

Abstract

Entities:  

Year:  2017        PMID： 28465516     DOI： 10.1038/leu.2017.14

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  6 in total

Review 1.  Novel approaches to therapy in CML.

Authors:  Ravi Bhatia
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

2.  MS4A3 promotes differentiation in chronic myeloid leukemia by enhancing common β-chain cytokine receptor endocytosis.

Authors:  Helong Zhao; Anthony D Pomicter; Anna M Eiring; Anca Franzini; Jonathan Ahmann; Jae-Yeon Hwang; Anna Senina; Bret Helton; Siddharth Iyer; Dongqing Yan; Jamshid S Khorashad; Matthew S Zabriskie; Anupriya Agarwal; Hannah M Redwine; Amber D Bowler; Phillip M Clair; Shannon K McWeeney; Brian J Druker; Jeffrey W Tyner; Derek L Stirewalt; Vivian G Oehler; Sooryanarayana Varambally; Kristofer C Berrett; Jeffery M Vahrenkamp; Jason Gertz; Katherine E Varley; Jerald P Radich; Michael W Deininger
Journal:  Blood       Date:  2022-02-03       Impact factor: 22.113

Review 3.  Targeting Abnormal Hematopoietic Stem Cells in Chronic Myeloid Leukemia and Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms.

Authors:  Yammy Yung; Emily Lee; Hiu-Tung Chu; Pui-Kwan Yip; Harinder Gill
Journal:  Int J Mol Sci       Date:  2021-01-11       Impact factor: 5.923

4.  Cryptotanshinone enhances the efficacy of Bcr-Abl tyrosine kinase inhibitors via inhibiting STAT3 and eIF4E signalling pathways in chronic myeloid leukaemia.

Authors:  Rubin Cheng; Yilan Huang; Yun Fang; Qirui Wang; Meixiu Yan; Yuqing Ge
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

Review 5.  Targeting STAT3 in Cancer with Nucleotide Therapeutics.

Authors:  Yue-Ting K Lau; Malini Ramaiyer; Daniel E Johnson; Jennifer R Grandis
Journal:  Cancers (Basel)       Date:  2019-10-29       Impact factor: 6.639

Review 6.  Overcoming Resistance to Kinase Inhibitors: The Paradigm of Chronic Myeloid Leukemia.

Authors:  Sara De Santis; Cecilia Monaldi; Manuela Mancini; Samantha Bruno; Michele Cavo; Simona Soverini
Journal:  Onco Targets Ther       Date:  2022-01-25       Impact factor: 4.147
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.